1) Bhalang K, Suesuwan A, Dhanuthai K, Sannikorn P, Luangjarmekorn L, Swasdison S. The application of acetic acid in the detection of oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106(3):371-376.
2) Kolanjiappan K, Ramachandran CR, Manoharan S. Biochemical changes in tumor tissues of oral cancer patients. Clin Biochem. 2003;36(1):61-65.
3) Brinkmann O, Kastratovic D, Dimitrijevic M, et al. Oral Squamous Cell Carcinoma detection by salivary biomakers in a Serbian Population. Oral Oncol. 2011;47(1):51-55.
4) Sharma S. Tumor markers in clinical practice: General principles and guidelines. Indian J Med Paediatr Oncol. 2009;30(1):1‑8.
5) Oyama T, Kawamoto T, Matsuno K, et al. A case study comparing the usefulness of serum trace elements (Cu, Zn and Se) and tumor markers (CEA, SCC and SLX) in non-small cell lung cancer patients. Anticancer Res. 2003;23(1B):605-612.
6) Plucinsky C, Riley WM, Prorok JJ, Alhadeff JA. Total and lipid associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastasis involvement. Cancer. 1986;58(12):2680-2685.
7) Harvey HA, Lipton A, White D, Davidson E. Glycoprotein's and human cancer II. Correlation between circulating levels and disease status. Cancer. 1981;47(2):324-327.
8) Nayyar A, Khan M, Ahmed I, Vijayalakshmi KR, Anitha M, Chendil V. Changing biochemical markers and ongoing process of transformation-a pilot study. International Journal of Physics and Mathematical Sciences. 2012;2(1):164-173.
9) Hershkovich O, Shafat I, Rafael MN. Age-related changes in salivary antioxidant profile: possible implications for oral cancer. J gerontol A Biol Sci Med Sci. 2007; 62(4): 361-366.
10) Khanna R, Thapa PB, Khanna S, Khanna AK, Shukla HS. Lipid peroxidation and antioxidant enzyme status in oral carcinoma patients. Kathmandu Univ Med J. 2005;3(4):334-339.
11) Bahar G, Feinmesser R, Shpitzer T, Popovtzer A, Rafael MN. Salivary analysis in oral cancer patients DNA and protein oxidation, reactive nitrogen species, and antioxidant profile. Cancer. 2007;109(1):54-59.
12) Singh A, Anitha M, Yadav MM. Serum albumin in poorly differentiated, oral squamous cell carcinoma: a possible diagnostic marker of significance. Arch oral res. 2011;7(3):251-257.
13) McPherson R. Specific proteins. In: McPherson RA, Pincus MR, editors. Henry's clinical diagnosis and management by laboratory methods. 21st ed. New York: WB Saunders; 2006: 110-112.
14) Azab B, Bhatt V, Vonfrolio S, Bachir R, Patel J. Value of the pretreatment albumin to globulin ratio in predicting long-term mortality in breast cancer patients. Am J surg. 2013;206(5):764-770.
15) Van der Waal I, Schepman KP, van der Meij EH. A modified classification and staging system for oral leukoplakia. Oral Oncol. 2000;36(3):264-266.
16) Barnes L, Everson JW. World Health Organization Classification of Tumours Pathology and Genetics of Head and Neck Tumours. IARC Press International Agency for Research on Cancer (IARC). 2005;167:177-179.
17) Leslie S, Mary G, Christian W. TNM Classification of Malignant Tumours. 7th edition (UICC). New York: Wiley. 2009;15-16.
18) Bryne M, Stromme H, Lileng R, Stene T, Bang G, Dabelsteen E. New malignancy grading is a better prognostic indicator than Broder's grading in oral squamous cell carcinoma. J Oral Pathol Med. 1989;18(8):432-437.
19) Bryne M, Koppang HS, Lilleng R, Kjaerheim A. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol. 1992;166(4):375-381.
20) Rastogi V, Puri N, Mishra S, Sharma R, Yadav L, Sabharwal R. Dilemmas in Grading Epidermoid Carcinoma. International Journal of Head and Neck Surgery. 2014;5(1):9-14.
21) Haliwell B. Oxidative stress and cancer, have we moved forward? Biochem J. 2007;401(1):1-11.
22) Manonaran S, Kolanjiappan K, Suresh J, Panchmurthy K. Lipid peroxidation and antioxidant status in patients with oral squamous cell carcinoma. Indian J Med Res. 2005;122(6):529-534.
23) Vijayamalini M, Manoharan S. Lipid peroxidation, vitamin C, E and reduced glutathione levels in patients with pulmonary tuberculosis. Cell Biochem Funct. 2003;22 (1):19-22.
24) Funda K, Bahad C, Melin AK, et al. Advanced oxidation protein products, Ferrous oxidation in xylenol orange and malondialdehyde levels in thyroid cancer. Ann surg oncol. 2007;14(9):2616-2620.
25) Chandran V, Anitha M, Avinash SS, et al. Protein oxidation: A potential cause of hypoalbuminemia in oral cancer. Biomed Res. 2012;23(2):227-230.
26) Onate-Ocana LF, Aiello-Crocifoglio V, Gallardo-Rincon D, et al. Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann Surg Oncol. 2007;14(2):381-389.
27) Boonpipattanapong T, Chewatanakornkul S. Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas. J Clin Gastroenterol. 2006;40(7):592-595.
28) Siddiqui A, Heinzerling J, Livingston EH, Huerta S. Predictors of early mortality in veteran patients with pancreatic cancer. Am J Surg. 2007;194(3):362-366.
29) Gupta D, Lis Christopher. Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature. Nutr J. 2010;9:69.
30) Asher V, Lee J, Bali A. Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer. Med Oncol. 2012;29(3):2005-2009.
31) Lis CG, Grutsch JF, Vashi PG, Lammersfeld CA. Is serum albumin an independent predictor of survival in patients with breast cancer? JPEN J Parenter Enteral Nutr. 2003;27(1):10-15.
32) Azab B, Kedia S, Shah N, et al. The value of the pretreatment albumin/globulin ratio in predicting the long-term survival in colorectal cancer. Int J Colorectal Dis. 2013;28(12):1629-1636.
33) Dawood RM, Hasan HR. Assessment of Salivary and Serum Proteins in Patients with Oral Tumors. J. Baghdad for Sci. 2013;10(3):934-944.
34) Oettl K, Stauber RE. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol. 2007;151(5):580-590.
35) Gutteridge JM. Antioxidant properties of the proteins caeruloplasmin, albumin and transferrin. A study of their activity in serum and synovial fluid from patients with rheumatoid arthritis. Biochim Biophys Acta. 1986;869(2):119-127.
36) Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87(1):315-424.
37) Carballal S, Radi R, Kir, MC, Barnes S, Freeman BA, Alvarez B. Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite. Biochemistry. 2003;42(33):9906-9914.
38) Simons JP, Schols AM, Buurman WA, Wouters EF. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci (Lond). 1999;97(2):215-223.
39) O'Gorman P, McMillan DC, McArdle CS. Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients. Nutr Cancer. 1998;32(2):76-80.
40) Barber MD, Ross JA, Fearon KC. Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer. 1999;35(2):106-110.
41) McMillan DC, Watson WS, O'Gorman P, Preston T, Scott HR, McArdle CS. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer. 2001;39(2):210-213.
42) Feller L, Altini M, Lemmer J. Inflammation in the context of oral cancer. Oral Oncol. 2013;49(9):887-892.
43) Jeng JH, Wang YJ, Chiang BL, et al. Roles of keratinocytes inflammation in oral cancer: regulating the prostaglandin E-2, interleukin-6 and TNF- alpha production of oral epithelial cells by areca nut extract and arecoline. Carcinogenesis. 2003;24(8):1301-1315.
44) Gashe JA, Hoffmann J, Boland CR, Goel A. Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells. Int J Cancer. 2011;129(5):1053-1063.